entertainment -WSS

entertainment

author：comprehensive 2025-10-01 00:06:12 - browse：3

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Bird flu in milk supply is likely coming from asymptomatic cows

leisure time

WSS

Why rehabilitation engineers need to center patients in their research

340B reform proposal comes out of Senate working group

Adopting new red light myopia treatments may be short

The Biogen Aduhelm mess could happen again

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Health care needs a new profession: neuroimaging counseling

explore

entertainment

explore

After affirmative action ruling, medical educators look to 'holistic review'

Problems with a popular proposal to regulate AI in health care

Supreme Court strikes down use of affirmative action

FTC falls short on scrutinizing hospital mergers, study says

Apple is now the first public company to be valued at $3 trillion

Close Medicare's dangerous gaps in addiction treatment coverage

The cancer drug shortage isn’t new — and neither are the solutions

MassMutual is introducing free genetic testing for members

ChatGPT in medicine: STAT answers readers' burning questions

Element Biosciences CEO lays out genome sequencing strategy

explore

Gene therapy for Afghan refugees’ infant will be fully covered

340B reform proposal comes out of Senate working group

Q&A: Jennifer Adair on making gene therapy available globally

Why Novartis is going to walk from its acquisition of MorphoSys

After traumatic brain injury, life support decisions can use more time

Texas Medical Board asked to define abortion emergency exception

focus

leisure time

explore

explore